Education and Information Transfer Core
Education and Information Transfer Core
批准号:
8870258
负责人:
LINDA J VAN ELDIK
金额:
$13.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-07-15 至
关键词:
Administrative SupplementAdolescentAfrican AmericanAgingAlzheimer&aposs DiseaseAlzheimer&aposs Disease Core CenterAreaAwarenessBooksBrainCaucasiansChurchClinicClinicalClinical ResearchClinical Research ProtocolsClinical TrialsClinical trial protocol documentCollaborationsCommunitiesCommunity ActionsDataDementiaDevelopmentDiseaseEducationEducation and OutreachElderlyEnrollmentEnsureEventFilmFocus GroupsFutureGoalsGrantHealthcareIndianaInstructionKentuckyLeadLinkMedical EducationMedical StudentsMedicineMinorityMinority GroupsMissionNeeds AssessmentOutreach ResearchParticipantPlayPoa plantPopulationProtocols documentationPublic RelationsResearchResearch PersonnelResearch SupportRoleRuralScientistStudentsSurveysTelemedicineTranslationsUnited States National Institutes of HealthUniversitiesUpdateWorkbasecaregiver educationcohortcollegecombatcommunity organizationsdesigninnovationmeetingsoutreachprogramsresearch studyresponsesymposium
中文摘要
项目总结(见说明):
教育和信息转移核心(EITC)是英国-ADC和
地方和州社区。EITC计划和活动已经创造并将保持一个受过教育的
当地社区渴望收到关于AD的最新信息并参与我们中心的研究。
通过EITC的努力,UK-ADC将继续与肯塔基州和英国合作,
指导州和机构的反应,以满足肯塔基州的痴呆症医疗保健需求。过去
五年来,EITC在开发创新产品以支持研究参与方面处于领先地位,
非裔美国人是肯塔基州最大的少数民族。EITC将继续与
部长理事会和社区行动理事会,以便使所开展的活动和产品,
作为阿尔茨海默氏症的非洲裔美国人教会和奶奶珍珠,一部电影,以教育非洲-
美国青少年对AD的认识,是顺应当地需求的. EITC招聘和外联活动将
与临床核心和网关卫星诊所密切协调,以确保适当的
确定参与者用于ADC队列、临床试验和其他研究。在EITC工作,
五年的资助期旨在达致三个特定目标。目标1是支持征聘工作,
我们中心的研究方案、临床试验和NIH/NIA计划的保留活动。核心地点
特别强调少数族裔的征聘和留用战略,并将继续其创新和
为非裔美国人的成功战略。一个扩大的目标是增加研究
参与,包括大脑捐赠。目的二是提高市民对广告的认识
重点是在非洲裔美国人社区保持强大的存在感。宣传努力
我将重点关注早期疾病识别的重要性,以支持我们中心的过渡主题
和翻译。目标3是扩大英国、社区和区域合作伙伴关系,以满足教育需求
社区和专业观众以及英国研究人员。与当地的紧密合作
老年痴呆症协会和老年教育中心将继续。根据需要评估和
根据调查数据,我们目前和未来的专业教育工作将集中在以下三个方面:
护理人员教育,医学生教育和科学会议,包括一个新的威廉R。
以我们前任主任的荣誉参加的马克斯伯里科学研讨会。
英文摘要
PROJECT SUMMARY (See instructions):
The Education and Information Transfer Core (EITC) functions as a vital link between the UK-ADC and
the local and state communities. EITC programs and activities have created and will maintain an educated
local community eager to receive updated information on AD and to participate in our Center's research.
Through EITC efforts, the UK-ADC will continue to work with both the Commonwealth of Kentucky and UK in
directing state and institutional response to meeting Kentucky's dementia health care needs. Over the past
five years, the EITC has taken a lead in developing innovative products to support research participation by
African Americans, the largest minority group in Kentucky. The EITC will continue strong relationships with
the Council of Ministers and the Community Action Council so that activities and products developed, such
as the Book of Alzheimer's for African-American Churches and Granny Pearl, a film to educate African-
American adolescents about AD, are responsive to local needs. EITC recruitment and outreach activities will
be closely coordinated with the Clinical Core and the Gateway Satellite Clinic to ensure that appropriate
participants are identified for ADC cohorts, clinical trials and other research studies. Work in the EITC forthe
five-year grant period will be designed to meet three specific aims. Aim 1 is to support recruitment and
retention activities for our Center's research protocols, clinical trials, and NIH/NIA initiatives. The core places
a special emphasis on minority recruitment and retention strategies, and will continue its innovative and
successful strategies for African American participants. An expanded goal is to increase research
participation, including brain donation, in this population. Aim 2 is to increase community awareness of AD
with an emphasis on maintaining a strong presence in the African-American community. Awareness efforts
will be focused on the importance of early disease identification to support our Center theme of transitions
and translation. Aim 3 is to expand UK, community and regional partnerships to meet the educational needs
of community and professional audiences and UK researchers. Strong collaborations with the local
Alzheimer's Association and Geriatric Education Center will continue. Based on needs assessment and
survey data, our current and future professional educational efforts will focus on the following three areas:
caregiver education, medical student education, and scientific conferences, including a new William R.
Markesbery scientific symposium in honor of our former director.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
-
批准号:10624841
-
项目类别:
-
资助金额:$154.73万
-
财政年份:2022
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
-
批准号:10608722
-
项目类别:
-
资助金额:$22.93万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core A: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10261962
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
University of Kentucky Alzheimer's Disease Research Center
-
批准号:10662314
-
项目类别:
-
资助金额:$288.09万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core G: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10662371
-
项目类别:
-
资助金额:$16.33万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core A: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10662339
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core A: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10459466
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core G: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10459472
-
项目类别:
-
资助金额:$16.33万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
University of Kentucky Alzheimer's Disease Research Center
-
批准号:10459464
-
项目类别:
-
资助金额:$293.7万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
University of Kentucky Alzheimer's Disease Research Center
-
批准号:10261961
-
项目类别:
-
资助金额:$300.99万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core G: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10261968
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
-
批准号:10307828
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2019
-
负责人:LINDA J VAN ELDIK
-
依托单位:
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
-
批准号:10061521
-
项目类别:
-
资助金额:$119.36万
-
财政年份:2019
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
-
批准号:9272346
-
项目类别:
-
资助金额:$146.89万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Microglia responses to CNS injury: targeting p38 MAPK signaling
-
批准号:8985734
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Microglia responses to CNS injury: targeting p38 MAPK signaling
-
批准号:9265338
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Microglia responses to CNS injury: targeting p38 MAPK signaling
-
批准号:9059183
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
-
批准号:9134677
-
项目类别:
-
资助金额:$140.34万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
-
批准号:8944142
-
项目类别:
-
资助金额:$141.63万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Modulation of CNS Proinflammatory Cytokine Production
-
批准号:7888622
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2010
-
负责人:LINDA J VAN ELDIK
-
依托单位:
海外基金